Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 201–300 of 1,014
Batchelor, P. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1185 · Cited by 198
“In vitro and in vivo perturbation studies have confirmed the importance of these inhibitors (McKeon et al., 1995; Yick et al., 2000; Moon et al., 2001; Bradbury et al., 2002), although with respect to myelin (reviewed Karim et al.”
BackgroundCellular transplantation strategies for spinal cord injury and translational neurobiology
Reier, P. J. (2004) · NeuroRX · doi:10.1602/neurorx.1.4.424 · Cited by 202
Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds
Katoh, H., Yokota, K., & Fehlings, M. G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00248 · Cited by 197
Galtrey, C. M., Kwok, J. C. F., Carulli, D., Rhodes, K. E., & Fawcett, J. W. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06108.x · Cited by 203
“The increased functional recovery of the CNS after chondroitinase treatment may also be due to increased plasticity, and modification of PNNs may be an important element of the effects of the enzyme (Bradbury et al., 2002; Caggiano et al., 2005; Massey et al., 2006; Galtrey & Fawcett, 2007).”
BackgroundSelf-citationTunable Growth Factor Delivery from Injectable Hydrogels for Tissue Engineering
Vulic, K., & Shoichet, M. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210638x · Cited by 199
Mizumoto, S., Yamada, S., & Sugahara, K. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.06.004 · Cited by 199
Lakatos, A., Barnett, S. C., & Franklin, R. J. M. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00270-x · Cited by 198
Brus-Ramer, M., Carmel, J. B., Chakrabarty, S., & Martin, J. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3489-07.2007 · Cited by 196
“Previous efforts have focused largely on neutralizing or abrogating growth inhibitory factors, either at the site of injury or in termination fields (Bradbury et al., 2002; Qiu et al., 2002; McGee and Strittmatter, 2003; Schwab, 2004; Massey et al., 2006), which augments the connectivity of all…”
BackgroundChau, C. H., Shum, D. K. Y., Li, H., Pei, J., Lui, Y. Y., Wirthlin, L., Chan, Y. S., & Xu, X. ‐. (2004) · The FASEB Journal · doi:10.1096/fj.03-0196fje · Cited by 198
“Although the enzyme had been used to treat lesioned CNS tissues in experimental animals (20, 21, 23), the lesions induced in the reported studies were considerably smaller than the hemisection gap in our current model.”
BackgroundMethodExtracellular matrix components associated with remodeling processes in brain
Rauch, U. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4043-x · Cited by 190
Proteoglycans and their roles in brain cancer
Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C., James, C. D., & Phillips, J. J. (2013) · The FEBS Journal · doi:10.1111/febs.12109 · Cited by 193
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity
Maier, I. C., & Schwab, M. E. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1890 · Cited by 196
“These fibres growing in adult CNS tissue seem to be able to recognize functionally meaningful targets; behavioural studies have shown recovery of locomotor as well as skilled forelimb movements in rats and mice in the absence of obvious malfunctions (Merkler et al. 2001; Bradbury et al. 2002; Li & Strittmatter 2003; L…”
BackgroundInfluentialM OLECULAR A PPROACHES TO S PINAL C ORD R EPAIR
David, S., & Lacroix, S. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094946 · Cited by 192
Anti‐Nogo on the go: from animal models to a clinical trial
Zörner, B., & Schwab, M. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05566.x · Cited by 189
Microglia-mediated degradation of perineuronal nets promotes pain
Tansley, S., Gu, N., Guzmán, A. U., Cai, W., Wong, C., Lister, K. C., Muñoz-Pino, E., Yousefpour, N., Roome, R. B., Heal, J., et al. (2022) · Science · doi:10.1126/science.abl6773 · Cited by 195
Self-citationJin, Y. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7980 · Cited by 193
“Enzymatic degradation of chondroitin sulfate has been shown to provide an effective strategy for improving regeneration of injured nigrostriatal axons (29) and of crushed corticospinal tract axons (3).”
BackgroundMethodDyck, S. M., & Karimi-Abdolrezaee, S. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.006 · Cited by 188
Sirko, S., von Holst, A., Wizenmann, A., Götz, M., & Faissner, A. (2007) · Development · doi:10.1242/dev.02871 · Cited by 196
“Interestingly, recent studies have proposed that CSPGs play important roles in the adult CNS as inhibitors of synaptic plasticity and of axonal regeneration in scar tissues (Bradbury et al., 2002; Pizzorusso et al., 2002).”
BackgroundResultIntracellular control of developmental and regenerative axon growth
Zhou, F.-Q., & Snider, W. D. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1882 · Cited by 186
“…of spinal cord myelin by inactivating PKC or blocking inhibitory effects of the glial scar by inactivating CSPGs allow limited regeneration of the central axons from DRG neurons in the dorsal column, but not corticospinal axons in the same location (Bradbury et al. 2002; Sivasankaran et al. 2004).”
BackgroundResultCaggiano, A. O., Zimber, M. P., Ganguly, A., Blight, A. R., & Gruskin, E. A. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.226 · Cited by 189
“Recent studies demonstrate that treatment of spinal cord injury models with chondroitinase, including a rat dorsal column surgical lesion (Bradbury et al., 2002) and cat spinal cord hemisection (Tester et al., 2003), re-sults in some degree of regeneration and functional recovery.”
InfluentialNeurological aspects of spinal-cord repair: promises and challenges
Dietz, V., & Curt, A. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70522-1 · Cited by 190
Grimpe, B., & Silver, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4986-03.2004 · Cited by 184
“…enzymatic digestion of just one of these components, the inhibitory glycosaminoglycan (GAG) chains of extracellular matrix PGs (McKeon et al., 1995; Bradbury et al., 2002; Pizzorusso et al., 2002; Tropea et al., 2003), is one of several key strategies that can be used to increase regeneration or…”
BackgroundCao, Z., Gao, Y., Bryson, J. B., Hou, J., Chaudhry, N., Siddiq, M., Martinez, J., Spencer, T., Carmel, J., Hart, R. B., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0815-06.2006 · Cited by 195
“Recent attempts to encourage regeneration by adult neurons have centered around elimination of the inhibitory signals via either blocking common receptors (Bradbury et al., 2002; Wang et al., 2002a,b; Domeniconi et al., 2002; Wong et al., 2002) or deletion of the inhibitory molecules themselves (Simonen et al.”
BackgroundExtracellular regulators of axonal growth in the adult central nervous system
Liu, B. P., Cafferty, W. B. J., Budel, S. O., & Strittmatter, S. M. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1891 · Cited by 188
“…liberation rat nigrostriatal lesion (Moon et al. 2001) N.T. N.T. N.T. regeneration of nigrostriatal tract GAG liberation rat dorsal column crush (Bradbury et al. 2002) yes N.T. yes electrophysiological and behavioral recovery TGFb decorin TGFb inhibition rat dorsal hemisection (Davies et al.…”
BackgroundInfluentialDrug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury
Kabu, S., Gao, Y., Kwon, B. K., & Labhasetwar, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.060 · Cited by 188
“The glycolytic enzyme chrondroitinase ABC (ChABC) has been investigated for its immunomodulatory benefits after it showed significant restoration of neuronal regeneration and plasticity by directly attacking the CSPG inhibitory activity in the glial scar in both small and large animal populations (38, 39).”
BackgroundScar-mediated inhibition and CSPG receptors in the CNS
Sharma, K., Selzer, M. E., & Li, S. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.009 · Cited by 188
“…pathways, including nigrostriatal, corticospinal, serotoninergic, reticulospinal, ascending dorsal column axons and Clarke's nucleus neurons (Barritt et al., 2006; Bradbury et al., 2002; Fouad et al., 2005; Garcia-Alias et al., 2009, 2011; Moon et al., 2001; Tom et al., 2009; Yick et al., 2000).”
BackgroundInfluentialMolecular determinants of retinal ganglion cell development, survival, and regeneration
Isenmann, S. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00027-2 · Cited by 192
Kaas, J. H., Qi, H.-X., Burish, M. J., Gharbawie, O. A., Onifer, S. M., & Massey, J. M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.014 · Cited by 191
“…through areas of decreased chondroitin sulfate proteoglycans expression and demonstrated subsequent functional recoveries (Yick et al., 2000; Bradbury et al., 2002; Yick et al., 2003; Chau et al., 2004; Davies et al., 2004; Yick et al., 2004; Fouad et al., 2005; Caggiano et al., 2005;…”
BackgroundProperzi, F., Carulli, D., Asher, R. A., Muir, E., Camargo, L. M., Van Kuppevelt, T. H., Ten Dam, G. B., Furukawa, Y., Mikami, T., Sugahara, K., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03876.x · Cited by 187
“The enzymatic removal of these chains from the CSPGs improves nerve fibre regeneration in vivo after nigrostriatal tract lesions and in the spinal cord after dorsal column transection (Moon et al., 2001; Bradbury et al., 2002).”
BackgroundSelf-citationGlycosaminoglycans from marine sources as therapeutic agents
Valcarcel, J., Novoa-Carballal, R., Pérez-Martín, R. I., Reis, R. L., & Vázquez, J. A. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.07.008 · Cited by 188
New insights into glial scar formation after spinal cord injury
Tran, A. P., Warren, P. M., & Silver, J. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03477-w · Cited by 182
Buss, A. (2004) · Brain · doi:10.1093/brain/awh001 · Cited by 184
“Myelin-associated proteins, extracellular matrix proteoglycans and barrier formation by reactive astrocytes are believed to play signi®cant roles in preventing axon regeneration in the CNS (Schafer et al., 1996; Schwab and Bartholdi, 1996; Bradbury et al., 2002).”
InfluentialAstrocyte function and role in motor neuron disease: A future therapeutic target?
Blackburn, D., Sargsyan, S., Monk, P. N., & Shaw, P. J. (2009) · Glia · doi:10.1002/glia.20848 · Cited by 179
“Likewise, chondroitinase treatment improves axon regeneration in experimental spinal cord injury (Bradbury et al., 2002).”
BackgroundReplication and reproducibility in spinal cord injury research
Steward, O., Popovich, P. G., Dietrich, W. D., & Kleitman, N. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.017 · Cited by 186
Massey, J. M., Amps, J., Viapiano, M. S., Matthews, R. T., Wagoner, M. R., Whitaker, C. M., Alilain, W., Yonkof, A. L., Khalyfa, A., Cooper, N. G. F., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.029 · Cited by 185
“…improvement after SCI. CSPGs limit both CNS axonal regeneration and functional plasticity (Davies et al, 1997; 1999; McKeon et al, 1991; Fitch and Silver, 1997; Bradbury et al., 2002; Grimpe and Silver, 2004; Pizzorusso et al, 2002; 2006; Barritt et al, 2006; Houle et al, 2006, Massey et al, 2006).”
BackgroundInfluentialRao, J.-S., Zhao, C., Zhang, A., Duan, H., Hao, P., Wei, R.-H., Shang, J., Zhao, W., Liu, Z., Yu, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804735115 · Cited by 181
“Bradbury EJ, et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury.”
BackgroundNishimura, S., Yasuda, A., Iwai, H., Takano, M., Kobayashi, Y., Nori, S., Tsuji, O., Fujiyoshi, K., Ebise, H., Toyama, Y., et al. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-3 · Cited by 179
“Chondroitinase ABC (ChABC), which digests CSPG, promotes axonal growth and the migration of grafted NS/PCs [49,50].”
Nonsteroidal Anti-Inflammatory Drugs Promote Axon Regeneration via RhoA Inhibition
Fu, Q., Hue, J., & Li, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4353-06.2007 · Cited by 183
Tsai, E. C., Dalton, P. D., Shoichet, M. S., & Tator, C. H. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269687 · Cited by 180
“…al., 2000; Schnell et al., 1994; Tuszynski et al., 1998), neutralization of inhibitory molecules that are believed to inhibit axonal regeneration (Bradbury et al., 2002; Fouad et al., 2001; Huang et al., 1999), and implantation of several types of cells (Coumans et al., 2001; Lu et al., 2002;…”
BackgroundAcute spinal cord injury: Pathophysiology and pharmacological intervention (Review)
Zhang, Y., Al Mamun, A., Yuan, Y., Lu, Q., Xiong, J., Yang, S., Wu, C., Wu, Y., & Wang, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12056 · Cited by 167
“ChABC treatment in rats can restore postsynaptic activity under injury, which is significant for the electrical stimulation of cortico‑ spinal neurons and enhances the functional recovery of motor and proprioceptive behavior (197).”
Madigan, N. N., McMahon, S., O’Brien, T., Yaszemski, M. J., & Windebank, A. J. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2009.08.015 · Cited by 178
“Furthermore, functional recovery in rats after SCI has been observed (Bradbury et al., 2002).”
Self-citationNakazaki, M., Morita, T., Lankford, K. L., Askenase, P. W., & Kocsis, J. D. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12137 · Cited by 176
“Reactive astrocytes form a glial scar and produce chondroitin sulfate proteoglycans (CSPGs) that can inhibit axonal growth (Bradbury et al., 2002) as do other endogenous inhibitory molecules that cause growth cone collapse (Schwab & Strittmatter, 2014).”
BackgroundLacroix, S., Havton, L. A., McKay, H., Yang, H., Brant, A., Roberts, J., & Tuszynski, M. H. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20051 · Cited by 174
Templated Agarose Scaffolds Support Linear Axonal Regeneration
Stokols, S., Sakamoto, J., Breckon, C., Holt, T., Weiss, J., & Tuszynski, M. H. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.2777 · Cited by 177
Blesch, A., & Tuszynski, M. H. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10934 · Cited by 179
“A lack of axonal responsiveness to GDNF might also arise from selective sensitivity of some axons to local inhibitors of growth, including myelin- and extracellular matrix-associated inhibitors (Davies et al., 1997; Bradbury et al., 2002; Pizzorusso et al., 2002).”
BackgroundBusch, S. A., Horn, K. P., Cuascut, F. X., Hawthorne, A. L., Bai, L., Miller, R. H., & Silver, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3705-09.2010 · Cited by 177
“The three major cell types in this compartment—neurons, NG2 cells, and macrophages— can be altered in many ways (Bradbury et al., 2002; Neumann et al., 2002; Horn et al., 2008; Ylera et al., 2009).”
BackgroundZhao, Y., Tang, F., Xiao, Z., Han, G., Wang, N., Yin, N., Chen, B., Jiang, X., Yun, C., Han, W., et al. (2017) · Cell Transplantation · doi:10.3727/096368917x695038 · Cited by 176
A Chondroitin Sulfate Small Molecule that Stimulates Neuronal Growth
Tully, S. E., Mabon, R., Gama, C. I., Tsai, S. M., Liu, X., & Hsieh-Wilson, L. C. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0484045 · Cited by 170
The Chemical Neurobiology of Carbohydrates
Murrey, H. E., & Hsieh-Wilson, L. C. (2008) · Chemical Reviews · doi:10.1021/cr078215f · Cited by 173
Axon Regeneration in the Mammalian Optic Nerve
Williams, P. R., Benowitz, L. I., Goldberg, J. L., & He, Z. (2020) · Annual Review of Vision Science · doi:10.1146/annurev-vision-022720-094953 · Cited by 176
Extracellular Matrix and Visual Cortical Plasticity
Berardi, N., Pizzorusso, T., & Maffei, L. (2004) · Neuron · doi:10.1016/j.neuron.2004.12.008 · Cited by 158
“…tPA hampers visualonal sprouting, and after injury they are upregulated in the CNS, with the effect of blocking axon regeneration cortical plasticity (Mataga et al., 1996; Muller and Griesinger, 1998), and MD is ineffective in mice with genetic(Bradbury et al., 2002; Silver and Miller, 2004).”
BackgroundDepletion of Perineuronal Nets in the Amygdala to Enhance the Erasure of Drug Memories
Xue, Y.-X., Xue, L.-F., Liu, J.-F., He, J., Deng, J.-H., Sun, S.-C., Han, H.-B., Luo, Y.-X., Xu, L.-Z., Wu, P., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5390-13.2014 · Cited by 176
“, 2002) and promotes the functional recovery of nervous system injury (Bradbury et al., 2002).”
BackgroundInfluentialCarmel, J. B., Berrol, L. J., Brus-Ramer, M., & Martin, J. H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1435-10.2010 · Cited by 171
“After injury, recovery of motor function, both spontaneous (Weidner et al., 2001) and with therapy (Schwab and Brösamle, 1997; Bradbury et al., 2002; Dergham et al., 2002; Tuszynski et al., 2003; Freund et al., 2006; Maier et al., 2008), is attributed to CST repair.”
BackgroundMethodIn Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells
Li, H., & Chen, G. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.004 · Cited by 172
“Reducing the activity of these factors promotes axonal regeneration in vivo (Alilain et al., 2011; Bradbury et al., 2002; GrandPré et al., 2002).”
Kitagawa, H., Izumikawa, T., Uyama, T., & Sugahara, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302493200 · Cited by 169
Gelain, F., Panseri, S., Antonini, S., Cunha, C., Donega, M., Lowery, J., Taraballi, F., Cerri, G., Montagna, M., Baldissera, F., et al. (2011) · ACS Nano · doi:10.1021/nn102461w · Cited by 175
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension
Gilbert, R. J., McKeon, R. J., Darr, A., Calabro, A., Hascall, V. C., & Bellamkonda, R. V. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.04.006 · Cited by 168
“…among a number of axon growth inhibitory molecules expressed in the adult CNS. Recent studies focusing on alleviation of CSPG inhibition demonstrate that in vivo delivery of the CS-GAG degrading enzyme chondroitinase ABC results in enhanced regeneration (Bradbury et al., 2002; Moon et al., 2001).”
BackgroundKlapka, N., Hermanns, S., Straten, G., Masanneck, C., Duis, S., Hamers, F. P. T., Müller, D., Zuschratter, W., & Müller, H. W. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04495.x · Cited by 170
“In another recent study (Bradbury et al., 2002), regeneration of CST axons, rated significant for a distance of 1 mm beyond the lesion epicentre, was observed 10 weeks after enzymatic degradation of chondroitin sulphate (CS) glycosaminoglycans, supporting our view that at least part of the inhibitory activity residing…”
BackgroundResultMiyata, S., & Kitagawa, H. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.06.010 · Cited by 171
The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170
Kwok, J. C. F., Carulli, D., & Fawcett, J. W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06878.x · Cited by 170
Self-citationKwok, J. C. F., Afshari, F., García-Alías, G., & Fawcett, J. W. (2008) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2008-00439 · Cited by 171
“Subsequently Bradbury and colleagues demonstrated regeneration of corticospinal axons and rapid behavioural recovery after chABC was infused into a crush injury in the dorsal funiculus in rats (Bradbury et al, 2002).”
Self-citationKanno, H., Pressman, Y., Moody, A., Berg, R., Muir, E. M., Rogers, J. H., Ozawa, H., Itoi, E., Pearse, D. D., & Bunge, M. B. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2661-13.2014 · Cited by 166
“…functional recovery observed after SCI. Degradation of CSPGs with chondroitinase ABC (ChABC) promotes axonal regeneration and functional recovery (Bradbury et al., 2002; Silver and Miller, 2004; Fouad et al., 2005; Barritt et al., 2006; Cafferty et al., 2007; Massey et al., 2008; Bradbury and…”
BackgroundRecent advances in managing a spinal cord injury secondary to trauma
Ahuja, C. S., Martin, A. R., & Fehlings, M. G. (2016) · F1000Research · doi:10.12688/f1000research.7586.1 · Cited by 164
Starkey, M. L., Barritt, A. W., Yip, P. K., Davies, M., Hamers, F. P. T., McMahon, S. B., & Bradbury, E. J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.017 · Cited by 172
Self-citationThe extracellular matrix and perineuronal nets in memory
Fawcett, J. W., Fyhn, M., Jendelova, P., Kwok, J. C. F., Ruzicka, J., & Sorg, B. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01634-3 · Cited by 169
Self-citationTyzack, G. E., Sitnikov, S., Barson, D., Adams-Carr, K. L., Lau, N. K., Kwok, J. C., Zhao, C., Franklin, R. J. M., Karadottir, R. T., Fawcett, J. W., et al. (2014) · Nature Communications · doi:10.1038/ncomms5294 · Cited by 167
Self-citationGaltrey, C. M., Asher, R. A., Nothias, F., & Fawcett, J. W. (2007) · Brain · doi:10.1093/brain/awl372 · Cited by 166
“Previous studies have demonstrated that the enzyme treatment exposes the sugar stubs that form the attachment site for chondrotin sulphate chains on the CSPG core proteins (Moon et al., 2001; Bradbury et al., 2002).”
BackgroundSelf-citationBranching morphogenesis and kidney disease
Shah, M. M., Sampogna, R. V., Sakurai, H., Bush, K. T., & Nigam, S. K. (2004) · Development · doi:10.1242/dev.01089 · Cited by 167
“A widely discussed hypothesis (Brenner et al., 1988) regarding the pathogenesis of certain forms of hypertension is based on the argument that inadequate nephron number (which correlates with reduced filtration surface area) results in increased glomerular volume and increased mean arterial…”
BackgroundSiddiqui, A. M., Khazaei, M., & Fehlings, M. G. (2015) · Progress in Brain Research · doi:10.1016/bs.pbr.2014.12.007 · Cited by 165
Ikegami, T., Nakamura, M., Yamane, J., Katoh, H., Okada, S., Iwanami, A., Watanabe, K., Ishii, K., Kato, F., Fujita, H., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04492.x · Cited by 164
“Bradbury et al. (2002) applied C-ABC (10 U ⁄mL) intrathecally to dorsally hemisected spinal cord and confirmed the digestion of CSPG within the spinal cord parenchyma by immunostaining with 2B6 antibody.”
BackgroundMethodInfluentialMultiple Regions of the NG2 Proteoglycan Inhibit Neurite Growth and Induce Growth Cone Collapse
Ughrin, Y. M., Chen, Z. J., & Levine, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00175.2003 · Cited by 165
“The administration of GAG lyases to damaged CNS tissue changes the environment in a manner that promotes axon regeneration (Moon et al., 2001; Bradbury et al., 2002; Zuo et al., 2002).”
BackgroundMechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
“In addition, astrocytes in injured areas release inhibitory extracellular matrix molecules known as chondroitin sulphate proteoglycans (CSPGs) which can severely in injured areas, affect both cytoskeleton and membrane components of growth cone architecture [113].”
BackgroundApostolova, I., Irintchev, A., & Schachner, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1526-06.2006 · Cited by 166
“Improved recovery from spinal cord injury after application of chondroitinase ABC (Bradbury et al., 2002) is possibly also attributable to enzymatic degradation of the perineuronal nets and concomitant removal of axon growth-inhibiting molecules such as chondroitin sulfate proteoglycans and TNR (Rhodes and Fawcett, 20…”
BackgroundNogo-A-Deficient Mice Reveal Strain-Dependent Differences in Axonal Regeneration
Dimou, L., Schnell, L., Montani, L., Duncan, C., Simonen, M., Schneider, R., Liebscher, T., Gullo, M., & Schwab, M. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1103-06.2006 · Cited by 162
“Functional importance of these factors has been demonstrated in vivo by inactivation experiments, in particular with regard to scar-associated chondroitin sulfate proteoglycans (Bradbury et al., 2002) and to Nogo-A (Schwab, 2004).”
BackgroundJones, L. L., & Tuszynski, M. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04611.2002 · Cited by 162
“…the possibility that proteoglycans participate in limiting axonal regeneration in the white matter of the CNS. Interestingly, general degradation of CSPGs after brain injury (Moon et al., 2001) and after SCI (Bradbury et al., 2002) enhances axonal growth and generates partial functional recovery.”
BackgroundBuchli, A. D., & Schwab, M. E. (2005) · Annals of Medicine · doi:10.1080/07853890500407520 · Cited by 166
“Local chondroitinase treatment to remove CSPGs in the scar promotes longdistance regeneration and enhances sprouting of lesioned axons in the nigrostriatal and spinal cord pathways (37,49).”
BackgroundHEINE, W., CONANT, K., GRIFFIN, J., & HOKE, A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.014 · Cited by 164
Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0038-0 · Cited by 163
“In response to injury, astrocytes, oligodendrocyte progenitors, and macrophages increase the expression of CSPGs, which in turn inhibit neurite outgrowth in vitro and regeneration in vivo [36, 37].”
BackgroundThe Therapeutic Role of Interleukin-10 after Spinal Cord Injury
Thompson, C. D., Zurko, J. C., Hanna, B. F., Hellenbrand, D. J., & Hanna, A. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2651 · Cited by 162
“…stem cell therapy, 4,5 peripheral nerve grafting, 6–8 transplantation of Schwann cells, 9,10 olfactory nervous system cell transplantation, 11,12 activated macrophage transplantation, 13–15 chondroitin sulfate degradation, 6,16,17 neurotrophin and growth factor delivery, 18,19 and immunomodulation.”
Repulsive Wnt Signaling Inhibits Axon Regeneration after CNS Injury
Liu, Y., Wang, X., Lu, C.-C., Sherman-Kermen, R., Steward, O., Xu, X.-M., & Zou, Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-08.2008 · Cited by 163
“Some improvement of regeneration is already shown when some of these inhibitors are blocked, particular by modifying the CSPGs with the enzyme ChABC (chondroitinase ABC) (Bradbury et al., 2002; Curinga et al., 2007).”
BackgroundActivating Transcription Factor 3 and the Nervous System
Hunt, D., Raivich, G., & Anderson, P. N. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00007 · Cited by 162
“…claimed to induce axonal regeneration by CNS neurons include antibodies to myelin proteins (Raineteau et al., 1999), administration of neurotrophins (Bradbury et al., 1999), administration of chondroitinase (Bradbury et al., 2002), and the implantation of olfactory glia (Li et al., 1997).”
BackgroundBurnside, E. R., & Bradbury, E. J. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12114 · Cited by 155
Self-citationChondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
Siebert, J. R., Conta Steencken, A., & Osterhout, D. J. (2014) · BioMed Research International · doi:10.1155/2014/845323 · Cited by 153
“Numerous in vivo studies have shown that by treating a CNS lesion site with the enzyme cABC, axonal sprouting, growth, and plasticity are significantly increased [139–147].”
BackgroundAxon regeneration through scars and into sites of chronic spinal cord injury
Lu, P., Jones, L. L., & Tuszynski, M. H. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.030 · Cited by 173
The biophysics of neuronal growth
Franze, K., & Guck, J. R. (2010) · Reports on Progress in Physics · doi:10.1088/0034-4885/73/9/094601 · Cited by 180
“In this context, it is intriguing to note that the treatment of glial scars with enzymes such as chondroitinase, which dissolves parts of the ECM, improves functional recovery after spinal cord injuries [247].”
BackgroundParikh, P., Hao, Y., Hosseinkhani, M., Patil, S. B., Huntley, G. W., Tessier-Lavigne, M., & Zou, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100426108 · Cited by 156
“Combinatorial strategies, such as relieving inhibition from CSPGs (42), cell grafting, or placement of growth factor gradients or guidance cues beyond lesion epicenter (43, 44), might lead to synergistic effects.”
BackgroundFawcett, J. W. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.02.001 · Cited by 172
Self-citationConversion in ASIA Impairment Scale during the First Year after Traumatic Spinal Cord Injury
Spiess, M. R., Müller, R., Rupp, R., Schuld, C., & van Hedel, H. J. A. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0760 · Cited by 162
Zhang, Y., Luo, H., Zhang, Z., Lu, Y., HUANG, X.-H., Yang, L., Xu, J. J., Yang, W., Fan, X.-J., Du, B., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.029 · Cited by 170
Regulation of intrinsic neuronal properties for axon growth and regeneration
Rossi, F., Gianola, S., & Corvetti, L. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.001 · Cited by 165
Angiogenesis in the ischemic core: A potential treatment target?
Kanazawa, M., Takahashi, T., Ishikawa, M., Onodera, O., Shimohata, T., & del Zoppo, G. J. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19834158 · Cited by 163
Camand, E., Morel, M., Faissner, A., Sotelo, C., & Dusart, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03558.x · Cited by 154
“, 2001) and the dorsal column tracts (Bradbury et al., 2002) after injury in the adult rat, suggesting an important role for these molecules in preventing axon regeneration.”
BackgroundTedeschi, A., & Bradke, F. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.12.005 · Cited by 164
Signaling the Pathway to Regeneration
Snider, W. D., Zhou, F., Zhong, J., & Markus, A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00762-6 · Cited by 176
“Approaches aimed at neu-The best-known example of a regeneration-associated protein is GAP43, an important regulator of growth cone tralizing these inhibitors have achieved some degree of regeneration after CNS lesions (Bradbury et al., 2002;motility during nervous system development.”
BackgroundDe Wit, J., De Winter, F., Klooster, J., & Verhaagen, J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.12.009 · Cited by 154
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Brown, J. M., Xia, J., Zhuang, B., Cho, K.-S., Rogers, C. J., Gama, C. I., Rawat, M., Tully, S. E., Uetani, N., Mason, D. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121318109 · Cited by 154
“For the antibody blocking study, biotinylated CS-E (10 nM in PBS) was preincubated with the CS-C antibody (6) or CS-E antibody (10 μM) for 1 h at RT.”
Axonal growth therapeutics: regeneration or sprouting or plasticity?
Cafferty, W. B. J., McGee, A. W., & Strittmatter, S. M. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.004 · Cited by 169
Chapter 23 The extracellular matrix in axon regeneration
Grimpe, B., & Silver, J. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)37025-0 · Cited by 185
Repair of chronic spinal cord injury
Houlé, J. D., & Tessler, A. R. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00029-3 · Cited by 164
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.